ANNX
USDAnnexon Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$2.660
High
$2.670
Low
$2.510
Volume
1.85M
Company Fundamentals
Market Cap
276.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.80M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical
HC Wainwright & Co. Maintains Buy on Annexon, Lowers Price Target to $14
HC Wainwright & Co. analyst Andrew Fein maintains Annexon with a Buy and lowers the price target from $20 to $14.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.